Streetbeat News

ZJYL

Jin Medical International Ltd.

https://www.zhjmedical.com

Industry

Medical - Instruments & Supplies

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Open

0.77

Mkt cap

133M

Volume

255K

High

0.85

P/E Ratio

42.59

52-wk high

4.77

Low

0.77

Div yield

N/A

52-wk low

0.59

In Friday's pre-market session, several healthcare stocks experienced significant movements. Jaguar Health (JAGX) saw the largest increase, with shares up by 37.0% to $0.15, while Estrella Immunopharma (ESLA) led the decliners, falling 14.9% to $0.86. Other notable gainers include Jin Medical International (ZJYL), Aileron Therapeutics (ALRN), Aditxt (ADTX), Akso Health Group (AHG), and DarioHealth (DRIO). On the losing side, MAIA Biotechnology (MAIA), Elevance Health (ELV), Stereotaxis (STXS), Humana (HUM), and Grifols (GRFS) also saw their share prices drop.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 1:06 pm

In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Exicure (XCUR) saw a 29.8% increase, while Telesis Bio (TBIO) rose by 21.88%. Jin Medical International (ZJYL) increased by 21.33%, Estrella Immunopharma (ESLA) by 15.78%, Amarin Corp (AMRN) by 15.35%, and Bio-Path Hldgs (BPTH) by 12.99%. Conversely, Aclaris Therapeutics (ACRS) fell by 14.1%, Forian (FORA) by 9.93%, Veradigm (MDRX) by 9.86%, cbdMD (YCBD) by 8.87%, ThermoGenesis Holdings (THMO) by 8.58%, and Qilian Intl Hldg Gr (QLI) by 8.32%.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 1:05 pm

In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Aura Biosciences (AURA) saw a 44.3% increase, while Galera Therapeutics (GRTX) rose 40.01%. Jin Medical International (ZJYL) and Seres Therapeutics (MCRB) also saw substantial gains. Conversely, Grifols (GRFS) and eFFECTOR Therapeutics (EFTR) faced sharp declines, along with Trevena (TRVN), Apollomics (APLM), Societal CDMO (SCTL), and Cyclacel Pharmaceuticals (CYCC).

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 1:06 pm

RxSight, Inc. (RXST) shares surged by 20% after providing FY23 and FY24 revenue guidance above estimates and following a price target increase by Needham. Other stocks experienced significant movement, with Harpoon Therapeutics, Inc. (HARP) and Ambrx Biopharma Inc. (AMAM) seeing major gains due to acquisition announcements. Conversely, LumiraDx Limited (LMDX) and Solo Brands, Inc. (DTC) faced steep declines, with LumiraDx facing Nasdaq suspension and Solo Brands lowering its full year 2023 revenue guidance.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 6:36 pm

Health care stocks experienced significant movement in Monday's intraday session. Harpoon Therapeutics (HARP) saw a 112.4% increase, while LumiraDx (LMDX) dropped by 45.6%. Other notable gainers include Ambrx Biopharma (AMAM), Nkarta (NKTX), Universe Pharmaceuticals (UPC), Elevation Oncology (ELEV), and Venus Concept (VERO). On the losing side, Revance Therapeutics (RVNC), Prothena Corp (PRTA), Inspire Veterinary (IVP), Pacific Biosciences (PACB), and Jin Medical International (ZJYL) saw declines.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 5:31 pm

Boeing shares fell 6.6% after an exit door blew out of a 737 aircraft, leading to the FAA grounding 171 jets. Other stocks also moved lower: Dada Nexus dropped 38.1% due to suspicious practices in revenue reporting; Solo Brands decreased 34.7% after cutting revenue guidance; Prothena fell 25.1% after program updates; Pacific Biosciences declined 15.1% with preliminary FY23 revenue announcement; and Spirit AeroSystems dropped 6.5% as it was involved with the faulty door on the Boeing aircraft.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 4:46 pm

The Greenbrier Companies, Inc. (NYSE:GBX) reported strong earnings, surpassing estimates with adjusted EPS of 96 cents against expected 73 cents. FY24 revenue is projected between $3.4 billion to $3.7 billion, compared to estimates of $3.58 billion. Greenbrier's shares jumped 13.8% to $50.50. Other stocks also moved higher, including AxoGen, Kura Sushi USA, Peloton Interactive, and Elanco Animal Health, following positive financial updates, upgrades, and executive announcements.

Portfolio Pulse from Avi Kapoor

January 05, 2024 | 3:18 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. Omega Therapeutics (OMGA) saw a 99.6% increase, while Avenue Therapeutics (ATXI) rose by 56.08%. Dyne Therapeutics (DYN) and Adicet Bio (ACET) also saw substantial gains. Conversely, SELLAS Life Sciences (SLS) and Relmada Therapeutics (RLMD) faced sharp declines, along with LifeMD (LFMD) and OPKO Health (OPK).

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:31 pm

SoFi Technologies, Inc. (SOFI) shares dropped by approximately 13% after Keefe, Bruyette & Woods downgraded the stock from Market Perform to Underperform and reduced the price target from $7.50 to $6.50. The downgrade was based on recent outperformance and changes in the analyst's model. Other stocks experienced significant movements in Wednesday's mid-day session, with various companies reporting gains due to positive developments such as regulatory approvals, partnership announcements, and favorable analyst ratings. Conversely, some stocks saw declines due to negative news such as poor earnings, strategic setbacks, or unfavorable analyst actions.

Portfolio Pulse from Avi Kapoor

January 03, 2024 | 5:58 pm

In Wednesday's intraday session, several healthcare stocks experienced significant movements. NexImmune (NEXI) saw a substantial increase of 230.5%, while ABVC BioPharma (ABVC) and First Wave BioPharma (FWBI) also posted notable gains. Conversely, Nemaura Medical (NMRD), TC BioPharm (TCBP), and Esperion Therapeutics (ESPR) were among the stocks that declined. These movements reflect the volatility and rapid changes in the healthcare sector, impacting the market value of these companies.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.